B BIIB

Biogen Inc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

Biogen Inc. is a leading biotechnology firm based in Cambridge, Massachusetts, renowned for its commitment to developing innovative therapies for neurological disorders. Focused on conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy, Biogen maintains a robust pipe...

$187.80

-1.45% ($2.76)

Volume 919,690

52W High $205.97

52W Low $121.05

Market Cap $27.95B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

May 6, 2026 Beat

Actual: $3.57 vs. Consensus: $3.03

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q1 2026 May 6, 2026

1-Day: +0.37%

5-Day: +3.81%

Q1 2026 Apr 29, 2026

1-Day: -2.62%

5-Day: -3.69%

Q4 2025 Feb 6, 2026

5-Day: -4.96%

Q4 2025 Jan 29, 2026

1-Day: +2.11%

5-Day: +0.33%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q1'26	$2.48B	+1.9%	73.3%	16.0%	$319.5M
Q4'25	$2.28B	-7.2%	78.2%	-2.5%	-$48.4M
Q3'25	$2.45B	-0.5%	64.3%	25.0%	$466.5M
Q2'25	$2.65B	+7.3%	64.2%	22.2%	$634.8M
Q1'25	$2.43B	+6.1%	76.2%	30.1%	$240.5M
Q4'24	$2.45B	+2.9%	76.2%	20.7%	$266.7M
Q3'24	$2.47B	-2.6%	74.1%	23.4%	$388.5M
Q2'24	$2.46B	+0.4%	61.2%	14.9%	$583.6M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q1 2026	May 6, 2026	$3.03	$3.35	$3.57	+17.82%	Beat
Q1 2026	Apr 29, 2026	$3.03	$3.33	$3.57	+17.82%	Beat
Q4 2025	Feb 6, 2026	$1.61	$1.80	$1.99	+23.60%	Beat
Q4 2025	Jan 29, 2026	$1.76	$1.90	$1.99	+13.07%	Beat
Q3 2025	Oct 30, 2025	$3.85	$4.24	$4.81	+24.94%	Beat
Q3 2025	Oct 29, 2025	$3.85	$4.12	$4.81	+24.94%	Beat
Q2 2025	Jul 31, 2025	$3.88	$4.15	$5.47	+40.98%	Beat
Q1 2025	May 1, 2025	$2.95	$3.16	$3.02	+2.37%	Missed
Q4 2024	Feb 12, 2025	$3.36	$3.57	$3.44	+2.38%	Missed
Q3 2024	Oct 30, 2024	$3.79	$4.05	$4.08	+7.65%	Met
Q2 2024	Aug 1, 2024	$4.03	$4.19	$5.28	+31.02%	Beat
Q1 2024	Apr 24, 2024	$3.45	$3.59	$3.67	+6.38%	Beat